CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ (DEFICIT) EQUITY - USD ($) $ in Thousands	Total	Restricted Stock	Common Stock [Member]	Common Stock [Member] Restricted Stock	Additional Paid-in Capital [Member]	Additional Paid-in Capital [Member] Restricted Stock	AOCI Attributable to Parent [Member]	Retained Earnings [Member]
Beginning balance (in shares) at Dec. 31, 2020			27,861,000
Beginning balance at Dec. 31, 2020	$ 157,192		$ 8		$ 551,429		$ (192)	$ (394,053)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of common stock options (in shares)			141,000
Stock Issued During Period, Value, Stock Options Exercised	2,155				2,155
APIC, Share-Based Payment Arrangement, Increase for Cost Recognition	50,224				50,224
Issuance of common stock (in shares)			724,000	42,000
Stock Issued During Period, Value, New Issues	0			$ 0	0
Stock Issued During Period, Value, Restricted Stock Award, Gross		$ 3,184
Adjustments to Additional Paid in Capital, Warrant Issued	841				841
Other comprehensive income (loss)	678						678
Net Income (Loss)	(128,565)							(128,565)
Ending balance (in shares) at Dec. 31, 2021			33,534,000
Ending balance at Dec. 31, 2021	690,700		$ 9		1,212,823		486	(522,618)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of common stock options (in shares)			23,000
Stock Issued During Period, Value, Stock Options Exercised	418				418
APIC, Share-Based Payment Arrangement, Increase for Cost Recognition	46,810				46,810
Issuance of common stock (in shares)				986,000
Stock Issued During Period, Value, New Issues				$ 0		$ 0
Stock Issued During Period, Value, Restricted Stock Award, Gross		0
APIC, Share-based Payment Arrangement, ESPP, Increase for Cost Recognition	1,997
Other comprehensive income (loss)	5,112						5,112
Net Income (Loss)	(465,264)							(465,264)
Ending balance (in shares) at Dec. 31, 2022			33,477,000
Ending balance at Dec. 31, 2022	211,605		$ 9		1,182,568		5,598	(976,570)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of common stock options (in shares)			10,000
Stock Issued During Period, Value, Stock Options Exercised	54
APIC, Share-Based Payment Arrangement, Increase for Cost Recognition	43,466				43,466
Issuance of common stock (in shares)			2,755,000	2,930,000
Stock Issued During Period, Value, New Issues	$ 15,171			$ 0	15,171
Stock Issued During Period, Value, Restricted Stock Award, Gross		$ 0
Proceeds from Stock Options Exercised					54
Issuance of ESPP (in shares)	657,826
Stock Issued During Period, Value, Employee Stock Purchase Plan	$ 2,335		$ 556		2,335
Other comprehensive income (loss)	(3,131)						(3,131)
Net Income (Loss)	(134,702)							(134,702)
Stock Issued During Period, Shares, Restricted Stock Award, Gross			167,000
Ending balance (in shares) at Dec. 31, 2023			39,728,000
Ending balance at Dec. 31, 2023	$ 134,798		$ 9		$ 1,243,594		$ 2,467	$ (1,111,272)